Wells Fargo & Company KYVERNA THERAPEUTICS INC Transaction History
Wells Fargo & Company
- $434 Billion
- Q3 2024
Number of Shares
153,787
Previous 112,709
36.45%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%